3Filing Date: Oct 5, 2026

Corteva (CTVA) 3: Sloan Jennifer L. initial ownership report (2 holdings) (Oct 5, 2026)

Initial Statement of Beneficial Ownership

View SEC Filing
ACC: 0001193125-26-414682
Total Value$0
Trades2
Insiders1

Transaction Details

Sloan Jennifer L.
Chief People Officer·Direct
Common Stock
Shares0
Price-
Total Value$0
Shares Owned After37.16K
Footnotes ▸

Includes 26,431.1139 unvested restricted stock units and related dividend equivalent units.

Sloan Jennifer L.
Chief People Officer·Direct
Non-Qualified Stock Option (right-to-buy)Derivative
Shares0
Price-
Total Value$0
Exercise Price$9.94
ExpiresFeb 28, 2033
Holding Only
Footnotes ▸

This option is fully vested and exercisable.

Post-Transaction Holdings

Sloan Jennifer L. · Chief People Officer
SecuritySharesChange
Common Stock37.16K-
Non-Qualified Stock Option (right-to-buy)--
Original SEC Filing Textexpand_more
=== SEC Form 3 — Statement of Changes in Beneficial Ownership === Document Type: 3 Period of Report: 2026-10-01 --- Issuer --- Name: Corteva, Inc. (CTVA) CIK: 0001755672 --- Reporting Owner --- Name: Sloan Jennifer L. CIK: 0002157638 Role: Officer (Chief People Officer) --- Holdings --- [Holding #1] Security: Common Stock Ownership: D (Direct) Footnotes: [F1] Includes 26,431.1139 unvested restricted stock units and related dividend equivalent units. [Holding #2] Security: Non-Qualified Stock Option (right-to-buy) Ownership: D (Direct) Footnotes: [F2] This option is fully vested and exercisable. [Holding #3] Security: Non-Qualified Stock Option (right-to-buy) Ownership: D (Direct) Footnotes: [F3] 5,005 options are vested and exercisable. The remaining options will vest on February 20, 2027. [Holding #4] Security: Non-Qualified Stock Option (right-to-buy) Ownership: D (Direct) Footnotes: [F4] 4,390 options are vested and exercisable. The remaining options will vest in two equal installments on on February 18, 2027 and February 18, 2028. --- Footnotes (Complete Index) --- F1: Includes 26,431.1139 unvested restricted stock units and related dividend equivalent units. F2: This option is fully vested and exercisable. F3: 5,005 options are vested and exercisable. The remaining options will vest on February 20, 2027. F4: 4,390 options are vested and exercisable. The remaining options will vest in two equal installments on on February 18, 2027 and February 18, 2028. --- Signature --- /s/ /s/Abigail Jarrell, by power of attorney (2026-10-05)

keid analysis is for reference only and does not constitute investment advice.